Labs / Assays & in vitro testing

3C Therapeutics
Vancouver, BC, Canada · 3ctherapeutics.com
GMP
3C Therapeutics develops degrader-antibody conjugates for cancer, with an initial focus on aggressive solid tumors. It is based in Vancouver, British Columbia, Canada, and works on partnered scientific collaborations and investment discussions.
They take quote requests by email.
What they offer
Degrader-antibody conjugate development
Develops DAC candidates by combining antibody-directed delivery with targeted protein degradation.
Targeted protein degradation platform development
Builds a proprietary TriCore platform to expand targeted protein degradation to harder-to-reach cancer targets.
Ligand design collaboration
Collaborates on hit-to-lead ligand design for DAC payloads and downstream candidate development.
DAC assembly and biological evaluation
Assembling degrader-antibody conjugates and evaluating them biologically as part of lead selection.
What they work on
- Modalities
- Antibody, ADC, Peptide, Cell therapy
- Assays and studies
- target engagement, protein degradation, biological evaluation
- Therapeutic areas
- cancer, oncology, solid tumors
- Sites
- Vancouver, Canada
- Address
- pairing 3C’s TriCore DAC platform with Variational AI’s Enki™ generati
Similar labs. ORF Biologics, Sparx BIO, Aurigene Pharmaceutical Services, Esco Aster
Found in a contract services directory. Listing built from 3ctherapeutics.com. Work here? Claim this listing.